Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act ...
1 hour ago
0
0
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with metastatic castration-resistant prostate cancer (mCRPC) in routine clinical practice, consistent with ...
8 hours ago
0
2
Male breast cancer is far less common than breast cancer in women, but it is usually discovered later: Men with breast cancer often receive the diagnosis after finding a breast lump on their own. Kathryn Ruddy, M.D., an oncologist ...
Oct 22, 2026
0
5
After years of rising sexually transmitted infection (STI) rates in Australia, new Burnet Institute–led research has found promising evidence that an existing antibiotic taken after sex may be helping to reduce syphilis and ...
Oct 21, 2026
0
9
Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes were associated with the future risk of developing prostate cancer, including aggressive disease, in a new study ...
Oct 21, 2026
0
10
Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An international team of researchers co-led by the Ontario Institute for Cancer Research (OICR) and ...
Oct 16, 2026
0
15
Approximately 1 in 4 active-duty male U.S. Army personnel may have a morning testosterone measurement below a commonly used clinical threshold, according to new research from Pennington Biomedical Research Center published ...
Oct 15, 2026
0
8
The rapid expansion of private testosterone prescribing risks extending treatment beyond men with clearly defined need to people with nonspecific symptoms and borderline test results, for whom the balance of benefit and long-term ...
Oct 14, 2026
0
5
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators ...
Oct 13, 2026
0
98
Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than they were a decade ago, according to an analysis by the London School of Hygiene & Tropical Medicine ...
Oct 8, 2026
0
8
